Interactive tools

Clinicians Explore Type 2 Inflammation Across Dermatologic Diseases

Oral Psoriasis Therapy: Response Over Time, Durability, and Monitoring

Don't Be Rash: When a Birthmark Is a Warning Sign

Experts Discuss Hedgehog Inhibitor Selection in Advanced BCC

Phase 3 Trial Supports Risankizumab for Pediatric Psoriasis

Dermatology Times Monthly FDA and Pipeline Review: October 2026

Gene Expression Profiling May Refine Cutaneous Melanoma Care

Pediatric Atopic Dermatitis: Skin Barrier Care and Early Biologic Use

Updated HS Guidelines Emphasize Biologics and Early Intervention

Study Links Agent Orange Exposure to Acral Melanoma in Veterans